AWMSG endorsed Antimicrobial Guidelines
Value-based prescribing
The All Wales Medicines Strategy Group (AWMSG) aims to encourage clinicians to prescribe medicines that offer the best health outcomes improving the quality of life for patients living in Wales. The overall aim of the value-based prescribing programme is to optimise the usage of medicines to deliver value. The document can be accessed here
Value-based prescribing – Strategy
National Prescribing Guidelines for Asthma and COPD (December 2021)
The national prescribing guidelines for asthma can be found at
All Wales adult asthma management and prescribing guideline - All Wales Medicines Strategy Group (nhs.wales). The national prescribing guidelines for COPD can be found at
All Wales COPD management and prescribing guideline - All Wales Medicines Strategy Group (nhs.wales)
LOCAL ANTIMICROBIAL GUIDELINES MARCH 2022
Prescribing Dilemmas
This document provides guidance for healthcare professionals regarding prescribing duration, foodstuffs, complementary medicines and alternative therapies, common ailments, fertility treatment, erectile dysfunction, prescribing for self and family, visitors from overseas, travel and occupational health vaccines, prescribing situations not covered by the NHS including private care and private prescriptions, unlicensed medicines and prescribing outside national guidance. The document can be accessed at
https://awmsg.nhs.wales/medicines-appraisals-and-guidance/medicines-optimisation/prescribing-guidance/prescribing-dilemmas-a-guide-for-prescribers/
Medicines optimisation framework
This framework details the processes behind the development of medicines optimisation resources that are endorsed and published by AWMSG, describes how new projects can be proposed and explains how these proposals are considered. The framework can be accessed at
https://awmsg.nhs.wales/medicines-appraisals-and-guidance/medicines-optimisation/medicines-optimisation-framework/
All Wales Multidisciplinary Reconciliation Policy
The All Wales Multidisciplinary Medicines Reconciliation Policy document has been developed to provide healthcare professionals with information to promote the safe and timely completion of medicines reconciliation and provides guidance on completing the process. The guidance can be accessed
here
Medicines Identified as Low Priority for Funding in NHS Wales
The Medicines Identified as Low Priority for Funding in NHS Wales document has been developed to provide healthcare professionals with information to minimise the prescribing of medicines that offer a limited clinical benefit to patients and where more cost effective treatments may be available. Five medicines have been identified for the purposes of this document: co-proxamol, lidocaine plasters, tadalafil once daily preparations, liothyronine and doxazosin modified release tablets. A guidance document has been prepared by the NHS Wales Pharmacy Directors with support from the All Wales Therapeutics and Toxicology Centre (AWTTC), and has been endorsed by the All Wales Medicines Strategy Group (AWMSG) at their October 2017 meeting. The guidance can be accessed
here
http://www.awmsg.org/